Latest filing published 13 May 2025 for Lifevantage Corp, €6,559.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Garry Paul Mauro (board member) discloses dealings in Lifevantage Corp to SEC (Form 4). In total, 23 filings cover trades dated from 2 February 2018 to 9 May 2025.
No open-market sale appears; the market trades are 6 purchases worth €48k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 8 share grants and 5 option exercises. 2025 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €7,605. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +13.0%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 13 May 2025, reports an open-market purchase of €6,559 in Lifevantage Corp. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations